The Therapeutic Effectiveness of Risperidone on Negative Symptoms of Schizophrenia in Comparison with Haloperidol: A Randomized Clinical Trial

The Therapeutic Effectiveness of Risperidone on Negative Symptoms of Schizophrenia in Comparison with Haloperidol: A Randomized Clinical Trial

Introduction: A number of research studies have shown that the new generation of neuroleptic medications can more effectively contribute to treating negative symptoms of schizophrenia compared with the first generation by influence cognitive functioning. The present study examined the therapeutic ef...

Full description

Bibliographic Details
Main Authors:	Arash Mirabzadeh, Pooneh Kimiaghalam, Farbod Fadai, Mercedeh Samiei, Reza Daneshmand
Format:	Article
Language:	English
Published:	Iran University of Medical Sciences 2014-07-01
Series:	Basic and Clinical Neuroscience
Subjects:	Risperidone Haloperidol Negative Symptoms Schizophrenia.
Online Access:	http://bcn.iums.ac.ir/browse.php?a_code=A-10-1-210&slc_lang=en&sid=1

Similar Items

The Effect of Risperidone on Cognitive Symptoms of Schizophrenia : A Comparison with Haloperidol
by: R. Daneshmand, M.D., et al.
Published: (2007-09-01)

Risperidone Provides Better Improvement of Sleep Disturbances Than Haloperidol Therapy in Schizophrenia Patients With Cannabis-Positive Urinalysis
by: Peta-Gaye L. Thomas-Brown, et al.
Published: (2018-07-01)

Efficacy of Risperidone Augmentation with Ondansetron in the Treatment of Negative and Depressive Symptoms in Schizophrenia: A Randomized Clinical Trial
by: Roya Samadi, et al.
Published: (2017-01-01)

Olanzapine has better efficacy compared to risperidone for treatment of negative symptoms in schizophrenia
by: P N Suresh Kumar, et al.
Published: (2016-01-01)

Effects of Haloperidol, Risperidone and Aripiprazole on the Immunometabolic Properties of BV-2 Microglial Cells
by: Valentino Racki, et al.
Published: (2021-04-01)

A CASE REPORT OF AN ULTRA-RAPID METABOLIZER ON DEPOT FORMULATIONS OF RISPERIDONE AND HALOPERIDOL AND REFLECTIONS ON METABOLIC PATHWAYS
by: Horst Koch, et al.
Published: (2014-09-01)

Effect of 5-HT6 Receptor Ligands Combined with Haloperidol or Risperidone on Antidepressant-/Anxiolytic-Like Behavior and BDNF Regulation in Hippocampus and Prefrontal Cortex of Rats
by: Wesołowska A, et al.
Published: (2021-06-01)

A Randomized Open Label Comparison of the Effects ofRisperidone and Haloperidol on Sexual Function
by: S. Jaber Mousavi, et al.
Published: (2009-09-01)

A Randomized Open Label Comparison of the Effects ofRisperidone and Haloperidol on Sexual Function
by: S. Jaber Mousavi, et al.
Published: (2009-12-01)

Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
by: Hikaru Hori, et al.
Published: (2018-03-01)

Effect of Ginkgo biloba, Risperidone and Biperiden regimen in chronic schizophrenia
by: Nikfarjam M (MD), et al.
Published: (2012-05-01)

Effects of the classical antipsychotic haloperidol and atypical anti-psychotic risperidone on weight gain, the oestrous cycle and uterine weight in female rats.
by: Fell, M.J., et al.
Published: (2009)

Comparison of tolerability between quetiapine and haloperidol in schizophrenia
by: Naba Raj Koirala, et al.
Published: (2012-12-01)

Efficacy of ziprasidone and risperidone in treatment of vagrants with schizophrenia
by: Zhan-Hua Li, et al.
Published: (2016-06-01)

A meta-analysis of phlegm-resolving Chinese medicine combined with risperidone for treatment of schizophrenia
by: Yong-Hou Zhao
Published: (2021-04-01)

Association of CYP2D6 polymorphisms and extrapyramidal symptoms in schizophrenia patients receiving risperidone: a retrospective study
by: Takahiro Ito, et al.
Published: (2018-11-01)

Evaluation of Clinical Outcome of Antipsychotic Therapy in Schizophrenic Patients in Palu - Indonesia
by: Astriana, et al.
Published: (2022)

Sodium Valproate as an Adjunctive to Risperidone in Treatment of Schizophrenia
by: V Omrani Fard, et al.
Published: (2007-01-01)

Rehospitalization rates of patients with schizophrenia discharged on haloperidol, risperidone or clozapine Taxas de re-hospitalização de pacientes após alta hospitalar em uso de haloperidol, risperidona ou clozapina
by: Ana Paula Werneck de Castro, et al.
Published: (2007-09-01)

Pervalence of Negative Symptoms in Schizophrenia
by: Saeed Shoja-Shefti, et al.
Published: (2002-10-01)

Evaluating the Effect of 8-Week Treatment With Risperidone On Fasting Blood Glucose of Patients with Schizophrenia
by: Firouzeh Raisi, et al.
Published: (2007-08-01)

Evaluating the Effect of 8-Week Treatment With Risperidone On Fasting Blood Glucose of Patients with Schizophrenia
by: Firouzeh Raisi, et al.
Published: (2007-09-01)

Negative symptoms in schizophrenia
by: Sayantanava Mitra, et al.
Published: (2016-01-01)

Risperidone associated paralytic ileus in schizophrenia
by: Parthasarathy Ramamourthy, et al.
Published: (2013-01-01)

The maintenance of modified electroconvulsive therapy combined with risperidone is better than risperidone alone in preventing relapse of schizophrenia and improving cognitive function
by: Ying Yang, et al.

Obsessive-Compulsive Symptoms Associated with Clozapine and Risperidone Treatment: Three Case Reports and Review of the Literature
by: Chiao-Li Ke, et al.
Published: (2004-06-01)

Risperidone induced angioedema with concurrent EPS symptoms: a case report and review of literature
by: Gursharan Singh Samra, et al.
Published: (2018-03-01)

An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
by: Pandina Gahan, et al.
Published: (2012-06-01)

Comparative study on clinically latent aggressiveness inoutpatients with schizophrenia treated with classical antipsychotics and with risperidone
by: Konstantinos Tsirigotis, et al.
Published: (2014-03-01)

Quality of life of patients suffering from schizophrenia and treated with long-acting risperidone and paliperidone-palmitate
by: Mihajlović Filip, et al.
Published: (2018-01-01)

The effectiveness and safety of amisulpride in Chinese patients with schizophrenia who switch from risperidone or olanzapine: a subgroup analysis of the ESCAPE study
by: Liang Y, et al.
Published: (2017-04-01)

Main methods of psychotherapy for negative schizophrenia symptoms
by: A. O Munin, et al.
Published: (2020-12-01)

Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
by: Hong Jihyung, et al.
Published: (2012-12-01)

C677T Polymorphism in the MTHFR Gene Is Associated With Risperidone-Induced Weight Gain in Schizophrenia
by: Jingping Liao, et al.
Published: (2020-07-01)

Effect of berberine combined with risperidone therapy on endocrine hormones and oxidative stress in patients with schizophrenia
by: Wei Dong, et al.
Published: (2017-07-01)

Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial
by: Charles Lung-Cheng Huang, et al.
Published: (2015-05-01)

Different effects of paliperidone and risperidone therapy on blood lipid and Hcy metabolism as well as endocrine hormones in patients with schizophrenia
by: Bei-Fang Fan, et al.
Published: (2017-11-01)

Obsessive-Compulsive Disorder in Hospitalized Patients with Schizophrenia
by: Mercedeh Samiei, et al.
Published: (2016-10-01)

Hyperprolactinaemia and menstrual irregularity emerging in association with risperidone use and treated with aripiprazole in an adolescent diagnosed with schizophrenia: a case report
by: Şermin Bilgen Ulgar, et al.
Published: (2018-10-01)

A case of generalized edema associated with risperidone monotherapy
by: Omer Asan, et al.
Published: (2019-12-01)

Cannot write session to /tmp/vufind_sessions/sess_33jdeevnnbm6sc4v63iq5bpl83